2021-01-11,Sarepta Stock Gets Mixed Reviews From Analysts
2021-01-11,Sarepta Stock Gains as CEO Explains What Went Wrong With Gene-Therapy Trial
2021-01-11,"SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"
2021-01-11,"SRPT Shareholder Alert - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Sarepta Therapeutics, Inc. Investigation"
2021-01-11,Gene-Therapy Firm Bluebird Bio Is Spinning Off Its Cancer Programs
2021-01-10,"SRPT Investor Alert - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Sarepta Therapeutics, Inc. Investigation"
2021-01-10,Here's Why Sarepta Therapeutics Lost Support on Wall Street
2021-01-09,"SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"
2021-01-09,"SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm - SRPT"
2021-01-08,Sarepta Stock Dropped 50% After Gene-Therapy Setback. What to Do Now.
2021-01-08,"SRPT INVESTIGATION ALERT: Bernstein Liebhard is Investigating Sarepta Therapeutics, Inc. For Violations of the Securities Laws"
2021-01-08,"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm"
2021-01-08,Sarepta Tanks On Likely 2-Year Delay For Muscular Dystrophy Gene Therapy
2021-01-08,"SRPT EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.  SRPT"
2021-01-08,"Dow Jones Falls As Economy Loses Jobs; Nio Hits New Buy Point, While Tesla Surges On New Model Y"
2021-01-08,Why Solid Biosciences Stock Is Sinking Today
2021-01-08,Is Sarepta Stock Worth Buying After the 50% Plunge? Analyst Weighs In
2021-01-08,Why Sarepta Therapeutics Stock Is Crashing Today
2021-01-08,ROCE Insights For Sarepta Therapeutics
2021-01-08,"Sarepta Craters, Cutting Market Value in Half on Therapy Miss"
2021-01-08,Sarepta Sinks on Disappointing Gene-Therapy Study Results
2021-01-08,Sarepta (SRPT) Down on Unsatisfactory Data for DMD Candidate
2021-01-08,Sarepta Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
2021-01-07,Sarepta stock plunges more than 50% after mixed results from drug study
2021-01-07,Sarepta Craters as Gene Therapy Miss Sparks Unease for Peers
2021-01-07,"Sarepta Therapeutics Announces Top-line Results for Part 1 of Study 102 Evaluating SRP-9001, its Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy"
2021-01-06,"This Small Gene Therapy Stock Is Taking On Giants Regeneron, Roche"
2021-01-05,Get Ready for Health-Care Stocks to Go Wild. How to Play Them.
2021-01-04,Unusual Options Activity Insight: Sarepta Therapeutics
2020-12-31,Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-12-24,"Breakeven On The Horizon For Sarepta Therapeutics, Inc. (NASDAQ:SRPT)"
2020-12-22,4 Biopharma Stock Picks From Analysts for 2021
2020-12-20,Is SRPT A Good Stock To Buy Now According To Hedge Funds?
2020-12-18,"Sarepta, Amicus Top Biotech Picks Ahead Of Key Binary Events: Analyst"
2020-12-14,Sarepta Therapeutics Announces Executive Management Changes
2020-12-09,Sarepta Therapeutics Sees Relative Strength Rating Improve To 74
2020-12-08,Sarepta (SRPT) DMD Study Shows Proof of Concept for SRP-5051
2020-12-07,Sarepta Therapeutics Earns Relative Strength Rating Upgrade
2020-12-07,"Sarepta Therapeutics Announces Positive Clinical Results from MOMENTUM, a Phase 2 Clinical Trial of SRP-5051 in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 51"
2020-12-05,Sarepta Therapeutics (SRPT) Up 8.9% Since Last Earnings Report: Can It Continue?
2020-12-04,"Sarepta Therapeutics to Share Clinical Update for SRP-5051, its Investigational PPMO for the Treatment of Duchenne Muscular Dystrophy"
2020-11-30,Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-11-25,Sarepta Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
2020-11-20,Sarepta Therapeutics Named One of The Boston Globes Top Places to Work 2020
2020-11-09,"Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Just Released Its Third-Quarter Earnings: Here's What Analysts Think"
2020-11-06,Sarepta Therapeutics Inc (SRPT): Are Hedge Funds Right About This Stock?
2020-11-06,Sarepta Therapeutics (SRPT) Q3 2020 Earnings Call Transcript
2020-11-06,"Sarepta (SRPT) Q3 Loss Widens Y/Y, Revenues Beat Estimates"
2020-11-05,This Biotech's Gene Therapy Sales Grew 23%  But That Wasn't Enough
2020-11-05,Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments
2020-11-05,Sarepta Therapeutics to Commence Dosing of the Next Study with Commercial Process Material for the SRP-9001 Gene Therapy Program for the Treatment of Duchenne Muscular Dystrophy
2020-11-05,"Sarepta Therapeutics, Inc. to Host Earnings Call"
2020-11-02,Sarepta Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
2020-10-30,Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-10-29,"Sarepta Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating"
2020-10-29,Analysts Estimate Sarepta Therapeutics (SRPT) to Report a Decline in Earnings: What to Look Out for
2020-10-29,"Sarepta Therapeutics to Announce Third Quarter 2020 Financial Results and Recent Corporate Developments on November 5, 2020"
2020-10-23,Is Sarepta Therapeutics (NASDAQ:SRPT) Weighed On By Its Debt Load?
2020-10-22,"Gene Therapy Company AavantiBio Launches with $107 Million Series A Financing from Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management and Sarepta Therapeutics"
2020-10-01,Pfizer Gets Fast-Track Status For Muscular Dystrophy Therapy
2020-10-01,Why Solid Biosciences Stock Has Doubled Today
2020-09-30,Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-09-28,"Sareptas First Gene-Therapy Test Patients Look Good, Two Years Out"
2020-09-28,"Sarepta Therapeutics Reports Sustained Functional Improvement Two Years After Treatment with SRP-9001, its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy"
2020-09-28,Sarepta Therapeutics Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Functional Improvements 18-months After Administration
2020-09-16,How Pfizer Plans to Lead the Industry in Gene Therapies
2020-09-15,"Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program"
2020-09-14,Long-term functional data from Sarepta Therapeutics Most Advanced Gene Therapy Programs to be Presented at Upcoming Annual Congress of the World Muscle Society
2020-09-10,Sarepta Therapeutics Stock Falls On Delay In Quest For Muscular Dystrophy Treatment
2020-09-10,FDA Delays Start of Sareptas Gene Therapy Trial. That Doesnt Faze the Stocks Bulls.
2020-09-10,Sarepta shares fall on potential regulatory delay for experimental Duchenne drug
2020-09-10,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial"
2020-09-09,"Sarepta Therapeutics Provides Program Update for SRP-9001, its Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy"
2020-09-08,Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)
2020-09-08,"If You Had Bought Sarepta Therapeutics (NASDAQ:SRPT) Stock Five Years Ago, You Could Pocket A 248% Gain Today"
2020-09-04,Why Is Sarepta Therapeutics (SRPT) Down 11.5% Since Last Earnings Report?
2020-09-03,Sarepta Therapeutics to Present at Upcoming Investor Conferences
2020-08-31,Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-08-26,5 Biotech Stocks That Could Be Worth a Look
2020-08-26,Sarepta's Casimersen NDA Gets Priority Review From FDA
2020-08-25,Sarepta Therapeutics Gets Fast-Track FDA Review For Muscular Dystrophy Drug
2020-08-25,Sarepta Therapeutics Stock Is Now a Top Idea at J.P. Morgan
2020-08-25,Sarepta Therapeutics Announces FDA Acceptance of Casimersen (SRP-4045) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45
2020-08-11,Goldman Sachs: These 3 Stocks Are Poised to Soar by at Least 30%
2020-08-11,Sarepta Therapeutics and University of Florida Announce Collaboration to Accelerate the Discovery and Development of Therapies for Rare Genetic Diseases
2020-08-06,"Sarepta (SRPT) Q2 Loss Widens Y/Y, Revenues Beat Estimates"
2020-08-05,"Sarepta Therapeutics (SRPT) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-05,Sarepta Therapeutics Announces Second Quarter 2020 Financial Results and Recent Corporate Developments
2020-07-31,Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-07-29,Will Sarepta Therapeutics (SRPT) Report Negative Q2 Earnings? What You Should Know
2020-07-29,"Sarepta Therapeutics to Announce Second Quarter 2020 Financial Results and Recent Corporate Developments on August 5, 2020"
2020-07-24,Does Sarepta Therapeutics' (NASDAQ:SRPT) CEO Salary Compare Well With The Performance Of The Company?
2020-07-24,Sarepta Therapeutics Receives Fast Track Designation for SRP-9001 Micro-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
2020-07-15,Sarepta Therapeutics Launches Rare Lessons Program to Promote Greater Diversity and Inclusion in the Classroom and Support Awareness of Rare Diseases
2020-07-10,Did Hedge Funds Make The Right Call On Sarepta Therapeutics Inc (SRPT) ?
2020-07-02,"The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts"
2020-07-02,Sarepta Therapeutics Signs Agreement with Hansa Biopharma for Imlifidase
2020-06-30,Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-06-30,"Sarepta Therapeutics Announces Retirement of Sandy Mahatme, Chief Financial Officer and Chief Business Officer"
2020-06-29,Sarepta Completes Rolling NDA Submission for New DMD Therapy
